Strain | % lesion size at: | ||
---|---|---|---|

Day 4 | Day 6 | Day 8 | |

Ea1189 | 8 | 51 (a) | 87 (abc) |

Δams mutant | 0 | 0 (b) | 0 (f) |

ΔhofC mutant | 6 | 46 (a) | 77 (bcde) |

ΔhofC/pJMK2 | 8 | 25 (b) | 79 (bcd) |

Δhof mutant | 4 | 29 (b) | 72 (de) |

Δhof/pJMK3 | 3 | 28 (b) | 92 (abc) |

ΔfimD mutant | 3 | 18 (b) | 57 (e) |

ΔfimD/pJMK4 | 2 | 34 (b) | 83 (abc) |

Δfim mutant | 4 | 41 (a) | 84 (abc) |

Δfim/pJMK5 | 3 | 45 (a) | 93 (abc) |

Δflg-3 mutant | 1 | 25 (b) | 93 (abc) |

Δflg-4 mutant | 2 | 23 (b) | 85 (abc) |

Δcrl mutant | 1 | 21 (b) | 76 (cde) |

Δcrl/pJMK6 | 9 | 57 (a) | 99 (a) |

Δeae mutant | 2 | 19 (b) | 80 (bcd) |

Δeae/pJMK7 | 9 | 58 (a) | 96 (ab) |

↵a Statistical analyses of treatment means (sizes of lesions caused by Ea1189 and various deletion mutants) was done by one-way analysis of variance, and mean separation (

*P*< 0.05) was accomplished with Fisher's protected least significant difference test. Means within a column followed by the same letter are not significantly different. No significant differences were observed on day 4.